3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
103
Lymphoma
68
Lymphoma, Large B-Cell, Diffuse
49
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Sarcoma
33
Lymphoma, Non-Hodgkin
29
Hodgkin Disease
28
Leukemia
23
Burkitt Lymphoma
22
Neoplasms
19
Lymphoma, Mantle-Cell
18
Triple Negative Breast Neoplasms
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, B-Cell
14
Lymphoma, Large-Cell, Anaplastic
12
Carcinoma, Hepatocellular
12
Breast Neoplasms, Male
11
Neuroblastoma
10
Recurrence
9
Ovarian Neoplasms
9
Neoplasm Metastasis
9
Inflammatory Breast Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, T-Cell
8
Osteosarcoma
7
Fallopian Tube Neoplasms
7
Urinary Bladder Neoplasms
6
Liposarcoma
6
Interventions
Taxes
2
Paclitaxel
2
Oxaliplatin
2
Magnesium Sulfate
2
Carboplatin
2
Calcium Gluconate
2
haloperidol decanoate
1
glutamic acid diethyl ester
1
axicabtagene ciloleucel
1
Vitamin E
1
Vincristine
1
Thalidomide
1
Surveys and Questionnaires
1
Rituximab
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Procarbazine
1
Peripheral Blood Stem Cell Transplantation
1
Pain Management
1
Modafinil
1
Methotrexate
1
Memantine
1
Melphalan
1
Lorazepam
1
Leucovorin
1
Lamotrigine
1
Ketamine
1
Interleukin 1 Receptor Antagonist Protein
1
In Situ Hybridization, Fluorescence
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neurotoxicity Syndromes
×
Doxorubicin
×
Clear all
No trials found.